本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tevogen Bio Holdings

0.9796
-0.0404-3.96%
盤後0.98000.0004+0.04%19:58 EDT
成交量:53.69萬
成交額:52.13萬
市值:1.80億
市盈率:-13.99
高:1.03
開:1.01
低:0.9200
收:1.02
資料載入中...
2025/04/18

重要事件披露

Form 8-K - Current report
2025/04/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

重要事件披露

Form 8-K - Current report
2024/11/19

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/01

SEC問詢函

Form CORRESP - Correspondence
2024/07/31

SEC問詢函

Form CORRESP - Correspondence
2024/07/29

SEC問詢函

Form CORRESP - Correspondence
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/22

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/22

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/30

重要事件披露

Form 8-K/A - Current report: [Amend]